Delisting risk
PMCB · NASDAQ · Biotechnology

PharmaCyte Biotech (PMCB)

Develops CypCaps, a cell-encapsulation pancreatic cancer therapy candidate.

$0.4808
At close−0.01 (−1.50%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Sep '24Dec '24Mar '25Aug '25Sep '25Dec '25Mar '26Jul '26
Reported$0.14−$0.29−$0.10$1.73−$0.09−$0.32$0.13−$0.01
Estimate−$0.06−$0.06
Surprise+316.7%+83.3%

RevenueReportedEstimate

Sep '24Dec '24Mar '25Aug '25Sep '25Dec '25Mar '26Jul '26
Reported
Estimate
Surprise

History

DateEstimateReportedSurprise
Jul 2026−$0.06−$0.01+83.3%
Jul 2026−$0.06
Mar 2026−$0.06$0.13+316.7%
Dec 2025−$0.32
Sep 2025−$0.09

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
Mar 2025
Dec 2024
Sep 2024
Aug 2024
Mar 2024
Dec 2023
Sep 2023
Jul 2023
Mar 2023
Dec 2022
Sep 2022
Jul 2022
Mar 2022
Dec 2021
Sep 2021
Aug 2021
Mar 2021
Dec 2020
Sep 2020
Aug 2020
Mar 2020
Dec 2019
Sep 2019
Aug 2019
Mar 2019
Dec 2018
Sep 2018
Jul 2018
Mar 2018
Dec 2017
Sep 2017
Jul 2017
Mar 2017
Dec 2016
Sep 2016
Jul 2016
Mar 2016
Dec 2015
Aug 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Jul 29, 2026−$0.06−$0.01+83.3%+2.5%
Jul 1, 2026−$0.06
Mar 17, 2026−$0.06$0.13+316.7%+1.5%
Dec 18, 2025−$0.32+2.1%
Sep 15, 2025−$0.09−1.9%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 11, 2025
Mar 17, 2025
Dec 13, 2024
Sep 16, 2024
Aug 13, 2024
Mar 18, 2024
Dec 15, 2023
Sep 18, 2023
Jul 31, 2023
Mar 16, 2023
Dec 14, 2022
Sep 14, 2022
Jul 28, 2022
Mar 15, 2022
Dec 14, 2021
Sep 14, 2021
Aug 10, 2021
Mar 12, 2021
Dec 11, 2020
Sep 11, 2020
Aug 13, 2020
Mar 13, 2020
Dec 23, 2019
Sep 13, 2019
Aug 12, 2019
Mar 14, 2019
Dec 14, 2018
Sep 12, 2018
Jul 20, 2018
Mar 19, 2018
Dec 14, 2017
Sep 13, 2017
Jul 27, 2017
Mar 13, 2017
Dec 2, 2016
Sep 6, 2016
Jul 29, 2016
Mar 8, 2016
Dec 10, 2015
Aug 24, 2015
Jul 29, 2015